KAM
CLB icon

Kopion Asset Management’s Core Laboratories CLB Stock Holding History

Kopion Asset Management’s Portfolio CLB Stock Details CLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-42,304
Closed -$1.65M – 19
2021
Q2 		$1.65M Sell
42,304
-13,756
-25% -$493K 1.14% 18
2021
Q1 		$1.61M Buy
56,060
+11,001
+24% +$376K 1.2% 18
2020
Q4 		$1.2M Buy
45,059
+10,769
+31% +$220K 0.96% 20
2020
Q3 		$523K Buy
34,290
+87
+0.3% +$1.82K 0.6% 21
2020
Q2 		$695K Sell
34,203
-10,510
-24% -$188K 0.79% 19
2020
Q1 		$462K Buy
44,713
+10,556
+31% +$295K 0.67% 19
2019
Q4 		$1.29M Buy
+34,157
New +$1.53M 1.28% 19

Other funds holding CLB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Kopion Asset Management's CLB Position: Q3 2021 in Review

Kopion Asset Management sold out of Core Laboratories (CLB) in Q3 2021, closing a stake of 42,304 shares — an estimated $1.65M sold.

Kopion Asset Management first reported a position in CLB in Q4 2019 and held it in 7 quarters. The position peaked at $1.65M in Q2 2021. 198 funds tracked by Wall St. Rank hold CLB as of Q3 2021.

  • Kopion Asset Management reported no remaining Core Laboratories position as of Q3 2021 after selling out during the quarter.
  • Kopion Asset Management sold 42,304 Core Laboratories shares in Q3 2021, an estimated $1.65M.
  • Kopion Asset Management first reported a position in Core Laboratories in Q4 2019 and held it in 7 quarters.
  • Kopion Asset Management's Core Laboratories position peaked at $1.65M in Q2 2021.
  • 198 funds tracked by Wall St. Rank held Core Laboratories as of Q3 2021.

Based on Kopion Asset Management's 13F filing for Q3 2021, filed 7 Oct 2021.